Markets:

Overview

News

Currencies

International

Treasuries

Alkermes plc - Ordinary Shares (NQ:ALKS)

31.63 +0.41 (+1.31%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Alkermes plc - Ordinary Shares

< Previous 1 2 Next >

Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1

January 06, 2026

From Alkermes plc

Via Business Wire

Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference

December 30, 2025

From Alkermes plc

Via Business Wire

Alkermes to Participate in Two Upcoming Investor Conferences

November 25, 2025

From Alkermes plc

Via Business Wire

Alkermes Honors Women's Equality Day

August 28, 2023

Via ACCESSWIRE

Alkermes Has Launched Employee Resource Groups

December 07, 2021

SOURCE: Alkermes

Via 3BL Media

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avadel Pharmaceuticals plc (Nasdaq – AVDL), Middlefield Banc Corp. (Nasdaq – MBCN), Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated

October 22, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Sarissa Capital Urges Alkermes Shareholders to Vote “FOR” Sarah Schlesinger and “WITHHOLD” Incumbent Director Richard Gaynor

June 28, 2023

From Sarissa Capital Management LP

Via Business Wire

Sarissa Issues Presentation Highlighting Sarissa Nominees Are Qualified to Create Value for Alkermes Shareholders

June 26, 2023

From Sarissa Capital Management LP

Via Business Wire

One Overdose Is Too Many

November 29, 2021

SOURCE: Alkermes

Via 3BL Media

Independent Proxy Advisory Firm ISS Agrees With Sarissa Capital That Shareholders’ Interests Would Be Best Served With Direct Shareholder Representation on the Alkermes Board

June 22, 2023

From Sarissa Capital Management LP

Via Business Wire

Independent Proxy Advisory Firm ISS Concludes That Sarissa Capital Has Made a Compelling Case for Change to the Alkermes Board

June 20, 2023

From Sarissa Capital Management LP

Via Business Wire

Sarissa Issues Presentation Highlighting the Need for Shareholder Representation on the Alkermes Board

June 15, 2023

From Sarissa Capital Management LP

Via Business Wire

Sarissa Urges Shareholders to Vote for Sarissa Nominees to Provide Much Needed Oversight and Accountability to Alkermes

June 13, 2023

From Sarissa Capital Management LP

Via Business Wire

Sarissa Capital Highlights Misleading Claims Made by Alkermes in Its Attempt to Thwart Shareholder Representation on the Board

June 09, 2023

From Sarissa Capital Management LP

Via Business Wire

Sarissa Urges Alkermes Shareholders to Vote the Universal Blue Card to Upgrade Alkermes for the Benefit of Shareholders

June 05, 2023

From Sarissa Capital Management LP

Via Business Wire

Sarissa Capital Comments on Alkermes Annual Meeting

July 06, 2022

From Sarissa Capital Management LP

Via Business Wire

Alkermes Announces 2022 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or Cancer

June 06, 2022

SOURCE: Alkermes

Via 3BL Media

Small-Cap Psychedelic Play Vying for Future Leadership in Addiction Treatment (AXSM, AWKNF, BICX, OPNT, ALKS, PFE, AMPH, OMER)

June 06, 2022

Via AB Newswire

Sarissa Condemns Poor Corporate Governance at Alkermes

May 27, 2022

From Sarissa Capital Management LP

Via Business Wire

New Findings About Life With Bipolar 1 Disorder

May 27, 2022

SOURCE: Alkermes

Via 3BL Media

Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028

May 26, 2022

Palm Beach, FL – May 26, 2022 – FinancialNewsMedia.com News Commentary – Worldwide, there is a rapid increase in the prevalence and incidence of neurological disorders such as multiple sclerosis,...

Via FinancialNewsMedia

Treating Bipolar 1 Disorder

May 24, 2022

SOURCE: Alkermes

Via 3BL Media

Alkermes Awarded 2022 Platinum Bell Seal for Workplace Mental Health

May 19, 2022

SOURCE: Alkermes

Via 3BL Media

Tips to Improve Mental Well-Being

May 17, 2022

SOURCE: Alkermes

Via 3BL Media

Alkermes Celebrates National Women's Health Week by Reminding You Why Regular Cancer Screenings Are Vital

May 13, 2022

SOURCE: Alkermes

Via 3BL Media

Alkermes to Highlight Data Related to Psychiatry Portfolio at Upcoming Scientific Conferences During Mental Health Awareness Month

May 06, 2022

SOURCE: Alkermes

Via 3BL Media

LGBTQ+ People Are More Likely to Experience a Mental Health Condition

April 27, 2022

SOURCE: Alkermes

Via 3BL Media

Topics LGBTQ

Rising Number of Mental Health Disorders Fuel Advancing Initiatives to Reduce Psychiatric and Neurological Conditions

March 08, 2022

Palm Beach, FL –– March 8, 2022 – FinancialNewsMedia.com News Commentary – According to a report from Grand View Research “High unmet medical needs and government initiatives to reduce the psychiatric...

Via FinancialNewsMedia

Topics Economy

Our Collective Responsibility to Respond Effectively to the Climate Crisis

December 03, 2021

SOURCE: Alkermes

Via 3BL Media

Alkermes in Action: Giving Tuesday

November 30, 2021

SOURCE: Alkermes

Via 3BL Media

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.